Proton Therapy for Kidney Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the safety of proton therapy, a type of radiation treatment, for kidney cancer in young patients. It targets those with conditions like Wilms tumor or clear cell sarcoma of the kidney who typically require radiation therapy. The study aims to identify any immediate side effects of this treatment. Individuals under 30 who need radiation for these specific kidney tumors might be suitable candidates for this study. As an Early Phase 1 trial, this research focuses on understanding how proton therapy affects young patients, offering them a chance to be among the first to receive this innovative treatment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that proton beam radiation is safe for treating renal tumors?
Research has shown that proton therapy is safe for people with kidney cancer. In one study, patients who received radiation for kidney tumors did not experience severe side effects. Some experienced only a slight decrease in kidney function, indicating that the treatment is generally well-tolerated. Another study found that patients who underwent proton therapy had fewer stomach and intestine problems, which are common with traditional radiation. These findings suggest that proton therapy might be a safer option for treating kidney cancer, with fewer immediate side effects compared to other treatments.12345
Why do researchers think this study treatment might be promising?
Proton beam radiation is unique for treating kidney cancer because it offers precision targeting of tumors while minimizing damage to surrounding healthy tissue. Unlike traditional radiation therapy, which uses X-rays, proton therapy uses positively charged particles that can be controlled more precisely, reducing side effects. This characteristic is particularly beneficial for patients with Wilms tumor or clear cell sarcoma of the kidney, as it allows for effective treatment with potentially fewer complications. Researchers are excited about this approach because it could enhance the quality of life for patients by preserving more of their healthy kidney function.
What evidence suggests that proton therapy is effective for kidney cancer?
Research has shown that proton beam therapy, the treatment under study in this trial, might be more effective than regular radiation for kidney tumors. One study found that proton therapy can focus radiation more precisely on the tumor, potentially protecting the surrounding healthy tissue. Another review noted that proton therapy usually causes fewer side effects than other radiation treatments. Although specific data for kidney cancer remains limited, early results suggest it could be a promising option.34678
Who Is on the Research Team?
Christine Hill-Kayser, MD
Principal Investigator
Children's Hospital of Philadelphia
Are You a Good Fit for This Trial?
This trial is for patients under 30 years old with renal tumors, specifically Wilms tumor or clear cell sarcoma of the kidney (CCSK), who need radiation therapy as part of their standard care. It's not open to those who are pregnant, breastfeeding, have had previous radiotherapy in the cancer area, or chemotherapy for these diagnoses.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Radiation
Participants receive pencil beam scanning proton therapy for renal tumors
Follow-up
Participants are monitored for acute toxicity and effectiveness after radiation therapy
What Are the Treatments Tested in This Trial?
Interventions
- Proton Beam Radiation
Proton Beam Radiation is already approved in European Union, United States, Japan, Canada for the following indications:
- Cancer of the brain and spinal cord
- Eye melanoma
- Head and neck cancers
- Breast cancer
- Lung cancer
- Liver cancer
- Pancreatic cancer
- Prostate cancer
- Brain tumors
- Eye melanoma
- Head and neck cancers
- Breast cancer
- Lung cancer
- Liver cancer
- Pancreatic cancer
- Prostate cancer
- Pediatric cancers
- Brain tumors
- Eye melanoma
- Head and neck cancers
- Breast cancer
- Lung cancer
- Liver cancer
- Pancreatic cancer
- Prostate cancer
- Brain tumors
- Eye melanoma
- Head and neck cancers
- Breast cancer
- Lung cancer
- Liver cancer
- Pancreatic cancer
- Prostate cancer
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital of Philadelphia
Lead Sponsor